Fosun Pharmaceutical

Company

Also known as: Fosun Pharma

Related News

European Biotechs Advance Next-Generation Immunotherapy Targets Beyond PD-1/PD-L1

May 01, 2026

European biotechs are exploring new immunotherapy targets beyond PD-1/PD-L1, including BTLA, TIGIT, and SLAMF6. Lund University researchers discovered a SLAMF6-mediated immune evasion mechanism. BioNTech and GenMab are advancing next-generation ICIs and bispecific antibodies through strategic partnerships.

LigaChem Accelerates ADC Pipeline Amid Losses, Lonza Expands Bioconjugate Capabilities

Apr 08, 2026

LigaChem Biosciences is expanding R&D investment in its ADC pipeline despite widening losses, with major clinical milestones expected this year. Concurrently, Lonza has enhanced its advanced synthesis capabilities for ADC development, including dual-payload technology and expanded Netherlands facility infrastructure.